“Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study”, J of Skin, vol. 4, no. 1, p. S12, Jan. 2020, Accessed: Apr. 19, 2025. [Online]. Available: https://skin.dermsquared.com/skin/article/view/826